MedPath

Evaluation of diagnostic test and curative effect for the superficial bladder cancer based oral 5-aminolevulinic acid (5-ALA) prior to transurethral resection (TUR)

Not Applicable
Conditions
superficial bladder cancer
Registration Number
JPRN-UMIN000035009
Lead Sponsor
Dokkyo Medical University, Department of Urology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
500
Inclusion Criteria

Not provided

Exclusion Criteria

progressive cancer

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath